Ping Liu

发表

[Multicenter clinical study about the action of Fuzheng Huayu Capsule against liver fibrosis with chronic hepatitis B].

Jun Ye, Yi-Yang Hu, Ping Liu, 2003, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Multicenter clinical study on Fuzhenghuayu capsule against liver fibrosis due to chronic hepatitis B.

Jun Ye, C. Liu, Yi-Yang Hu, 2005, World journal of gastroenterology.

Classification of Gan Dan Shi Re Pattern and Gan Shen Yin Xu Pattern in Patients with Hepatitis B Cirrhosis Using Metabonomics

Xiao-Jun Gou, Ping Liu, Yue Gao, 2018, Evidence-based complementary and alternative medicine : eCAM.

A comparative analysis of methods for probability estimation tree

Ping Liu, Na Chu, Lizhuang Ma, 2011 .

Tai Chi on bone mineral density of postmenopausal osteoporosis

Ping Liu, Hai-Yang Wu, Yiru Wang, 2020, Medicine.

microRNA-322/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2/HIF-1α pathway.

Y. Lei, Ping Liu, Cheng-Hai Liu, 2020, Life Science.

[Combined use of factor analysis and cluster analysis in classification of traditional Chinese medical syndromes in patients with posthepatitic cirrhosis].

Ping Liu, Jian-Jun Wei, Jian-jun Wei, 2005, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[Biochemical characteristics of traditional Chinese medicine syndromes and their elements in patients with hepatitis B cirrhosis].

Ping Liu, Ji-li Yuan, Lei Wang, 2011, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[Clinical investigation on characteristics of traditional Chinese medical syndrome of hepatocirrhosis].

Y. Liu, Jian-jun Wei, Ping Liu, 2003, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B.

C. Liu, Yi-Yang Hu, Ping Liu, 2002, World journal of gastroenterology.

Salvianolic acid B attenuates the inflammatory response in atherosclerosis by regulating MAPKs/ NF-κB signaling pathways in LDLR-/- mice and RAW264.7 cells

Ping Liu, Yifan Zhang, Xiaoteng Feng, 2022, International journal of immunopathology and pharmacology.

Conjugated secondary 12α-hydroxylated bile acids promote liver fibrogenesis

Suwen Zhao, Wei Jia, Beicheng Sun, 2021, EBioMedicine.

Vitamin D for inflammation biomarkers in coronary artery disease

Ping Liu, Yiyi Zhang, Yiru Wang, 2020, Medicine.

Does omega-3 lower blood pressure?

Xiaohong Chen, Ping Liu, Yiru Wang, 2020, Medicine.

The Role of Lymphangiogenesis in Coronary Atherosclerosis.

Ping Liu, M. Du, Yiru Wang, 2021, Lymphatic research and biology.

Immunomodulation and liver protection of Yinchenhao decoction against concanavalin A-induced chronic liver injury in mice.

Ping Liu, Xu-Dong Hu, Shi-li Jiang, 2015, Journal of integrative medicine.

Chinese medicines as a resource for liver fibrosis treatment

Y. Tong, Ning Wang, Yibin Feng, 2009, Chinese medicine.

The role and mechanism of tetramethylpyrazine for atherosclerosis in animal models: A systematic review and meta-analysis

Ping Liu, Yiru Wang, Xiaoteng Feng, 2022, PloS one.

Urine metabolic profile changes of CCl4-liver fibrosis in rats and intervention effects of Yi Guan Jian Decoction using metabonomic approach

Yu Zhao, Xiao-Jun Gou, Q. Feng, 2013, BMC Complementary and Alternative Medicine.

A Metabolite Array Technology for Precision Medicine.

J. Nicholson, Wei Jia, Beicheng Sun, 2021, Analytical chemistry.

TGF-β1/p65/MAT2A pathway regulates liver fibrogenesis via intracellular SAM

Daming Gao, Lihong Hu, Hu Zhou, 2019, EBioMedicine.

Effect of salvianolic acid B on collagen production and mitogen-activated protein kinase activity in rat hepatic stellate cells.

C. Liu, Yi-Yang Hu, Ping Liu, 2002, Acta pharmacologica Sinica.

A Review on the Nonpharmacological Therapy of Traditional Chinese Medicine with Antihypertensive Effects

A. Yang, Ping Liu, Youhua Wang, 2019, Evidence-based complementary and alternative medicine : eCAM.

Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.

Zheng-Tao Wang, Yiyu Lu, S. Su, 2016, Journal of ethnopharmacology.

Efficacy and Safety of a Botanical Formula Fuzheng Huayu for Hepatic Fibrosis in Patients with CHC: Results of a Phase 2 Clinical Trial

J. Glenn, T. Hassanein, H. Makhlouf, 2022, Evidence-based complementary and alternative medicine : eCAM.

Rubus chingii Hu. unripe fruits extract ameliorates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance

Ping Liu, Yongbin Xu, Wei Liu, 2022, Chinese Medicine.

Identification and pharmacokinetics of multiple constituents in rat plasma after oral administration of Yinchenzhufu decoction.

Ping Liu, Cheng-Hai Liu, Yueming Ma, 2014, Journal of ethnopharmacology.

Identification of diagnostic biomarkers and therapeutic targets in peripheral immune landscape from coronary artery disease

Ping Liu, Yiru Wang, J. Ding, 2022, Journal of translational medicine.

Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice

Yi-Yang Hu, Ping Liu, Cheng-Hai Liu, 2015, BMC Complementary and Alternative Medicine.

The diversity and plasticity of adult hepatic progenitor cells and their niche

M. Zern, N. Theise, Yuyou Duan, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Clinical Study of Effects of Jian Ji Ning, a Chinese Herbal Medicine Compound Preparation, in Treating Patients with Myasthenia Gravis via the Regulation of Differential MicroRNAs Expression in Serum

Jingsheng Zhang, Ping Liu, Chao Jiang, 2014, Evidence-based complementary and alternative medicine : eCAM.

Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of Qing-Fei-Pai-Du decoction by UHPLC-Q-Exactive-Orbitrap HRMS.

Guangbo Ge, Ling Yang, Ping Liu, 2020, Chinese journal of natural medicines.

Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.

W. Liu, Ping Liu, Y. Mu, 2017, The American journal of Chinese medicine.

Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation.

C. Liu, Ping Liu, Cheng-Hai Liu, 2017, The American journal of Chinese medicine.

Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats

C. Liu, Wen-gang Yang, Yi-Yang Hu, 2010, Laboratory Investigation.

The effects of inhibiting the activation of hepatic stellate cells by lignan components from the fruits of Schisandra chinensis and the mechanism of schisanhenol

Ping Liu, Y. Mu, Hua Zhang, 2020, Journal of Natural Medicines.

Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.

Ping Liu, Mingyu Sun, Y. Mu, 2016, Journal of ethnopharmacology.

A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease

Yi Du, N. Zhang, Ping Liu, 2019, Medicine.

Music Intervention in Pain Relief of Cardiovascular Patients in Cardiac Procedures: A Systematic Review and Meta-analysis.

Ping Liu, Yiyi Zhang, Yiyi Zhang, 2020, Pain medicine.

Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/− Mice Induced by Hyperlipaemia

Ping Liu, Shengchao Lin, Hewei Qin, 2015, Evidence-based complementary and alternative medicine : eCAM.

Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats

Ping Liu, Yu Huang, Youhua Wang, 2014, British journal of pharmacology.

Metabolomics Analysis Delineates the Therapeutic Effects of Huangqi Decoction and Astragalosides on α-naphthylisothiocyanate (ANIT) -Induced Cholestasis in Rats.

G. Xie, Ping Liu, Jia Liu, 2020, Journal of ethnopharmacology.

Active Compounds Derived from Fuzheng Huayu Formula Protect Hepatic Parenchymal Cells from Apoptosis Based on Network Pharmacology and Transcriptomic Analysis

S. Su, Ping Liu, Shu Dong, 2019, Molecules.

Effects of Moxa Smoke on Monoamine Neurotransmitters in SAMP8 Mice

Baixiao Zhao, L. Lao, Ping Liu, 2013, Evidence-based complementary and alternative medicine : eCAM.

Management of Hepatic Encephalopathy by Traditional Chinese Medicine

G. Xie, Houkai Li, Xiaojiao Zheng, 2012, Evidence-based complementary and alternative medicine : eCAM.

Effects of Yinchenhao Tang and related decoctions on DMN-induced cirrhosis/fibrosis in rats

C. Liu, Ping Liu, Mingyu Sun, 2008, Chinese medicine.

Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells

Ping Liu, Hailin Yang, Y. Mu, 2020, Pharmaceutical biology.

Shi's Yi-Qi Bu-Shen Tong-Luo decoction combined with manipulation in the management of wrist stiffness after distal radius fracture

Ping Liu, Hai-Yang Wu, Yiru Wang, 2020, Medicine.

Urinary Metabolite Profiling Offers Potential for Differentiation of Liver-Kidney Yin Deficiency and Dampness-Heat Internal Smoldering Syndromes in Posthepatitis B Cirrhosis Patients

G. Luo, G. Xie, Xiaoyan Wang, 2015, Evidence-based complementary and alternative medicine : eCAM.

Antitumor Activities of Kushen: Literature Review

Yi-Yang Hu, Ping Liu, Shu Dong, 2012, Evidence-based complementary and alternative medicine : eCAM.

Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review

Ping Liu, Mingyu Sun, Hong-yan Cao, 2014, BioMed research international.

Salvianolic Acid B Attenuates Rat Hepatic Fibrosis via Downregulating Angiotensin II Signaling

Ping Liu, Lina Wang, Qinglan Wang, 2012, Evidence-based complementary and alternative medicine : eCAM.

Rapid, reliable, and sensitive detection of adenosine deaminase activity by UHPLC‐Q‐Orbitrap HRMS and its application to inhibitory activity evaluation of traditional Chinese medicines

W. Liu, T. Yang, Changhong Wang, 2018, Journal of pharmaceutical and biomedical analysis.

Effect of Fuzheng Huayu formula and its actions against liver fibrosis

Yi-Yang Hu, Ping Liu, Lieming Xu, 2009, Chinese medicine.

Differences in Metabolites of Different Tongue Coatings in Patients with Chronic Hepatitis B

Ping Liu, Qin Feng, Shi-bing Su, 2013, Evidence-based complementary and alternative medicine : eCAM.

Comparative Study of TCM Syndrome Scale for Liver Disease and Chronic Liver Disease Questionnaire Based on Assessment of Posthepatitic Cirrhosis

Ping Liu, Hua Zhang, Yan Lin, 2012, Evidence-based complementary and alternative medicine : eCAM.

Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis.

Weian Yuan, Ping Liu, Hua Zhang, 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition).

Ping Liu, Lie-Ming Xu, 2020, Journal of integrative medicine.

Effects of endocrine disrupting chemicals in host health: Three-way interactions between environmental exposure, host phenotypic responses, and gut microbiota.

Ping Liu, Chundi Xu, Na Li, 2020, Environmental pollution.

Inhibition of notch signaling pathway prevents cholestatic liver fibrosis by decreasing the differentiation of hepatic progenitor cells into cholangiocytes

M. Zern, Ping Liu, Y. Mu, 2016, Laboratory Investigation.

Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activation.

Ping Liu, Y. Mu, Hua Zhang, 2015, Journal of ethnopharmacology.

Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure

Herbert Yu, W. Jia, Wei Jia, 2018, EBioMedicine.

Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage

Ping Liu, Y. Mu, Hua Zhang, 2020, Frontiers in Pharmacology.

Bile Acid Profiles Are Distinct among Patients with Different Etiologies of Chronic Liver Disease.

Wei Jia, G. Xie, K. Zhou, 2021, Journal of proteome research.

Sorafenib inhibits transforming growth factor β1‐Mediated Epithelial‐Mesenchymal Transition and apoptosis in mouse hepatocytes

Ping Liu, Cheng-Hai Liu, Mingyu Sun, 2011, Hepatology.

Efferocytosis in multisystem diseases

Ping Liu, Yiru Wang, Yifan Zhang, 2021, Molecular medicine reports.

Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis

Fengjie Huang, Sha Lei, Wei Jia, 2016, International journal of cancer.

Research Progress on the Antitumor Effects of Rhein: Literature Review.

Ping Liu, Shu Dong, Mingyu Sun, 2018, Anti-cancer agents in medicinal chemistry.

Hai Hu, Ping Liu, Qun Zhou, 2021, Experimental and therapeutic medicine.

Glial cell line-derived neurotrophic factor (GDNF) mediates hepatic stellate cell activation via ALK5/Smad signalling

S. Dooley, Jianrong Xu, E. Seki, 2019, Gut.

Serum Bile Acids Are Associated with Pathological Progression of Hepatitis B-Induced Cirrhosis.

Wei Jia, G. Xie, Xiaojiao Zheng, 2016, Journal of proteome research.

Ingredients of Huangqi decoction slow biliary fibrosis progression by inhibiting the activation of the transforming growth factor-beta signaling pathway

Yi-Yang Hu, Ping Liu, Cheng-Hai Liu, 2012, BMC Complementary and Alternative Medicine.

Transcriptional Profiling and miRNA-Target Network Analysis Identify Potential Biomarkers for Efficacy Evaluation of Fuzheng-Huayu Formula-Treated Hepatitis B Caused Liver Cirrhosis

Mei Wang, Yiyu Lu, S. Su, 2016, International journal of molecular sciences.

Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis

Ping Liu, Hui Zhang, Shi-Bing Su, 2015, Evidence-based complementary and alternative medicine : eCAM.

Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning

Runmin Wei, Sandi Kwee, Wei Jia, 2018, EBioMedicine.

Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease

Ruixin Zhu, S. Baker, R. Baker, 2017, Oncotarget.

[Establishment and analysis of serum two-dimensional gel electrophoresis profiles of myasthenia gravis patients with spleen and kidney deficiency syndrome].

Yi-yi Zhang, Ping Liu, J. Qiao, 2007, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Fuzheng Huayu recipe, a traditional Chinese compound herbal medicine, attenuates renal interstitial fibrosis via targeting the miR-21/PTEN/AKT axis.

Ping Liu, Qinglan Wang, Y. Tao, 2020, Journal of integrative medicine.

Xuefuzhuyu decoction inhibition of angiogenesis attenuates liver fibrosis induced by CCl₄ in mice.

T. Yang, Ping Liu, Mingyu Sun, 2014, Journal of ethnopharmacology.

[Development of the integrated TCM hepatology with western medicine].

Ping Liu, 2003, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Capsaicin receptor TRPV1 maintains quiescence of hepatic stellate cells in the liver via recruitment of SARM1.

S. Dooley, B. Kobe, Q. Zhai, 2023, Journal of hepatology.

Effects of Moxa (Folium Artemisiae argyi) Smoke Exposure on Heart Rate and Heart Rate Variability in Healthy Young Adults: A Randomized, Controlled Human Study

Baixiao Zhao, L. Lao, Ping Liu, 2013, Evidence-based complementary and alternative medicine : eCAM.

MicroRNA-744/transforming growth factor β1 relationship regulates liver cirrhosis

Shuang Huang, Ping Liu, Y. Mu, 2019, Hepatology International.

The effect and mechanisms of Fuzheng Huayu formula against chronic liver diseases.

Ping Liu, Y. Mu, Long Chen, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Huangqi decoction inhibits apoptosis and fibrosis, but promotes Kupffer cell activation in dimethylnitrosamine-induced rat liver fibrosis

Ping Liu, Mingyu Sun, Y. Mu, 2012, BMC Complementary and Alternative Medicine.

Neurotropin Inhibits Lipid Accumulation by Maintaining Mitochondrial Function in Hepatocytes via AMPK Activation

R. Gottlieb, E. Seki, A. Stotland, 2020, Frontiers in Physiology.

Poly‐pharmacokinetic Study of a Multicomponent Herbal Medicine in Healthy Chinese Volunteers

Wei Jia, G. Xie, Tianlu Chen, 2018, Clinical pharmacology and therapeutics.

ERRATUM: Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.

Ping Liu, Y. Mu, Qun Zhou, 2019, The American journal of Chinese medicine.

Pharmacokinetics and anti-liver fibrosis characteristics of amygdalin: Key role of the deglycosylated metabolite prunasin.

Changhong Wang, Ping Liu, Xuemei Cheng, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Distinctly altered gut microbiota in the progression of liver disease

Wei Jia, Defa Li, Wenlian Chen, 2016, Oncotarget.

Fuzheng Huayu Capsule (扶正化瘀胶囊) in the treatment of liver fibrosis: Clinical evidence and mechanism of action

Ping Liu, 2012, Chinese Journal of Integrative Medicine.

Salvianolic Acid B Enhances Hepatic Differentiation of Human Embryonic Stem Cells Through Upregulation of WNT Pathway and Inhibition of Notch Pathway.

M. Zern, Xiaocui Ma, Yuyou Duan, 2017, Stem cells and development.

MicroRNA-101 inhibits renal tubular epithelial-to-mesenchymal transition by targeting TGF-β1 type I receptor

Ping Liu, Qinglan Wang, Y. Tao, 2021, International journal of molecular medicine.

[Dynamic expression of matrix metalloproteinase-2, membrane type-matrix metalloproteinase-2 in experimental hepatic fibrosis and its reversal in rat].

Ping Liu, S. Xin, Guang-de Zhou, 2004, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

The sodium new houttuyfonate suppresses NSCLC via activating pyroptosis through TCONS‐14036/miR‐1228‐5p/PRKCDBP pathway

Rilei Jiang, Ping Liu, F. Feng, 2023, Cell proliferation.

Herbal medicine Yinchenhaotang protects against α-naphthylisothiocyanate-induced cholestasis in rats

P. Hu, Wei Jia, G. Xie, 2017, Scientific Reports.

[Classification and modeling of traditional Chinese medicine syndromes in patients with post-hepatitic cirrhosis by partial least-squares].

S. Su, Ping Liu, Lei Wang, 2008, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: involvement of alleviating intestinal microbiota dysbiosis.

Ping Liu, Hua Zhang, Yueming Ma, 2020, Journal of ethnopharmacology.

Mechanisms of Huangqi Decoction Granules (黄芪汤颗粒剂) on Hepatitis B Cirrhosis Patients Based on RNA-Sequencing

Ping Liu, Yang Cheng, Tian-lu Hou, 2018, Chinese Journal of Integrative Medicine.

Simultaneous quantification of multiple components in rat plasma by UPLC-MS/MS and pharmacokinetic study after oral administration of Huangqi decoction.

Ping Liu, Hua Zhang, Yueming Ma, 2018, Biomedical chromotography.

Actions of Huangqi decoction against rat liver fibrosis: a gene expression profiling analysis

Yiyu Lu, S. Su, Ping Liu, 2015, Chinese Medicine.

Serum miR-21 and miR-26a Levels Negatively Correlate with Severity of Cirrhosis in Patients with Chronic Hepatitis B.

Ping Liu, Y. Mu, Xiaoning Wang, 2018, MicroRNA.

Inhibition of pathological angiogenesis of Chinese medicine against liver fibrosis

Ping Liu, 2016, Chinese Journal of Integrative Medicine.

Expression of matrix metalloproteinases in liver tissues with nonalcoholic steatohepatitis

Ping Liu, Guang-de Zhou, Jing-min Zhao, 2002 .

[Clinical effect of sirolimus in treatment of blue rubber bleb nevus syndrome in children: a report of 2 cases and literature review].

Ping Liu, Xu Quan, Yuan Xiao, 2020, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

Rough set based feature selection for improved differentiation of traditional Chinese medical data

Lizhuang Ma, Yang Zhou, Ping Liu, 2010, 2010 Seventh International Conference on Fuzzy Systems and Knowledge Discovery.

Automatic differentiation system for posthepatitic cirrhosis in traditional Chinese medicine

Lizhuang Ma, Ping Liu, Na Chu, 2010, The 2010 IEEE International Conference on Information and Automation.

[Strategy for treating liver fibrosis by integration of the disease and its syndromes in traditional Chinese medicine].

Ping Liu, 2004, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

Farnesoid X receptor is an important target for the treatment of disorders of bile acid and fatty acid metabolism in mice with nonalcoholic fatty liver disease combined with cholestasis

G. Xie, Ping Liu, Xiaoning Wang, 2023, Journal of gastroenterology and hepatology.

Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

F. Lu, Shuohui Yang, Yu Zhao, 2023, BMC Complementary Medicine and Therapies.

Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism

Yiyu Lu, S. Su, Ping Liu, 2013, Evidence-based complementary and alternative medicine : eCAM.